Efficacy and Safety of Sofosbuvir Containing Regimens for the Treatment of Chronic HCV Infection in Participants With Chronic Genotype 1, 2, 3, or 6 HCV Infection

NCT01826981 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

359

Enrollment

INDUSTRY

Sponsor class

Conditions

Chronic Hepatitis C

Interventions

DRUG: LDV/SOF
DRUG: SOF
DRUG: RBV
DRUG: Peg-IFN
DRUG: GS-9669
DRUG: VEL

Sponsor

Gilead Sciences